Literature DB >> 21372192

Influence of biological agents on cardiovascular disease in rheumatoid arthritis.

Johan Askling, Will Dixon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21372192     DOI: 10.1136/ard.2010.142174

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

Review 1.  Inflammation as a mediator of arterial ageing.

Authors:  Daniel W Trott; Paul J Fadel
Journal:  Exp Physiol       Date:  2019-08-08       Impact factor: 2.969

Review 2.  Biologics registers in RA: methodological aspects, current role and future applications.

Authors:  Elena Nikiphorou; Maya H Buch; Kimme L Hyrich
Journal:  Nat Rev Rheumatol       Date:  2017-06-01       Impact factor: 20.543

Review 3.  Coagulation and the fibrin network in rheumatic disease: a role beyond haemostasis.

Authors:  Berthold Hoppe; Thomas Dörner
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

4.  An Observational Study of Cardiovascular Risks Associated with Rheumatoid Arthritis Therapies: A Comparison of Two Analytical Approaches.

Authors:  Lisa J Herrinton; G Thomas Ray; Jeffrey R Curtis; Jashin J Wu; Bruce Fireman; Liyan Liu; Robert Goldfien
Journal:  Perm J       Date:  2018

5.  Validation of the rheumatoid arthritis diagnosis in the Swedish National Patient Register: a cohort study from Stockholm County.

Authors:  Kristin Waldenlind; Jonas K Eriksson; Bernhard Grewin; Johan Askling
Journal:  BMC Musculoskelet Disord       Date:  2014-12-15       Impact factor: 2.362

6.  Analysis of Drug Effects on Primary Human Coronary Artery Endothelial Cells Activated by Serum Amyloid A.

Authors:  K Lakota; D Hrušovar; M Ogrič; K Mrak-Poljšak; S Čučnik; M Tomšič; B Božič; P Žigon; S Sodin-Semrl
Journal:  Mediators Inflamm       Date:  2018-02-13       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.